Lonza Expands Product Lifecycle Management CapabilitiesAllbiopro2018-09-21T01:46:33+09:009월 21st, 2018|
FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medicationsAllbiopro2018-09-20T03:25:09+09:009월 20th, 2018|
California Insurance Commissioner Files Fraud Complaint Against AbbVieAllbiopro2018-09-20T03:24:37+09:009월 20th, 2018|
GSK Nabs Boehringer Ingelheim’s Chief Medical Officer Christopher CorsicoAllbiopro2018-09-20T03:24:09+09:009월 20th, 2018|
FDA Requests Another Trial for Pharming’s Ruconest Label ExpansionAllbiopro2018-09-20T03:23:41+09:009월 20th, 2018|
57% of Americans OK with Genetically Engineering Animals for Organ TransplantsAllbiopro2018-09-20T03:23:13+09:009월 20th, 2018|
Clovis Oncology to Pay the SEC $20 Million for Misleading InvestorsAllbiopro2018-09-20T03:22:45+09:009월 20th, 2018|
AstraZeneca’s Asthma Drug Looks Good in Multiple Late-Stage TrialsAllbiopro2018-09-20T03:22:17+09:009월 20th, 2018|
Zealand Pharma’s Phase III Severe Hypoglycemia Rescue Treatment Hits the Mark in Clinical TrialAllbiopro2018-09-20T03:21:50+09:009월 20th, 2018|
U.K. court invalidates Gilead’s Truvada patent extension, allowing PrEP genericsAllbiopro2018-09-20T03:20:55+09:009월 20th, 2018|
England’s cost watchdogs nix Novartis’ Kymriah for adultsAllbiopro2018-09-20T03:19:52+09:009월 20th, 2018|
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag: reportAllbiopro2018-09-20T03:19:18+09:009월 20th, 2018|
Amgen leaves celeb spokeswoman Blythe Danner behind in newest Prolia adAllbiopro2018-09-20T03:18:49+09:009월 20th, 2018|
Chris Corsico jumps from Boehringer to head development at GSKAllbiopro2018-09-20T03:18:20+09:009월 20th, 2018|
Galera reels in $150M to test radiation side effect drug in phase 3Allbiopro2018-09-20T03:17:52+09:009월 20th, 2018|
Polverino swaps interim CSO role at Kite for permanent gig at ZymeworksAllbiopro2018-09-20T03:17:23+09:009월 20th, 2018|
